{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T13:32:40Z","timestamp":1782567160024,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013739","name":"Pfizer Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Abnormal uterine bleeding (AUB), which includes heavy menstrual bleeding (HMB), is a common condition placing women at increased risk for developing iron deficiency and iron deficiency anemia (IDA). Depletion of iron stores has negative implications on physical, social, and emotional health, as well as quality of life. Iron supplements are safe, effective, and readily available, while red blood cell (RBC) transfusions have inherent risks including infectious and immune reactions. Despite high prevalence of IDA among women with AUB, there are limited studies on the impact of iron therapies on patient outcomes. This systematic review and meta-analysis will evaluate the impact of iron supplementation on patient outcomes for women with AUB, when compared to combination therapy, no intervention, placebo, or standard of care.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We will conduct a systematic review and meta-analysis of randomized controlled trials and observational studies evaluating the impact of iron interventions on patient outcomes for women with AUB. Systematic literature searches will be conducted in major databases including MEDLINE, EMBASE, CENTRAL, CINAHL, and Web of Science. Studies assessing the impact of iron interventions on patient outcomes in women experiencing AUB, in comparison to combination therapy, no intervention, placebo, or standard of care, will be included in the review. Independent reviewers will screen for eligibility, assess risk of bias, and abstract data. Overall certainty of evidence for each outcome will be assessed using the GRADE approach. We will meta-analyze outcomes which are sufficiently homogeneous to summarize intervention effects and narratively synthesize nonhomogeneous outcomes. The main outcomes of interest are hemoglobin levels immediately prior to surgery and post-operatively, number of RBC transfusions, and adverse effects. Secondary outcomes will include length of hospital stay, intraoperative blood loss, adverse and side effects, quality of life, and iron indices.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This review will evaluate the impact of iron interventions on patient outcomes in women with IDA secondary to AUB with focus on changes in hematological and iron indices, red blood cell utilization, quality of life, cost of treatment, and adverse events. The results will inform evidence-based clinical practice for the management of iron deficiency and IDA secondary to AUB.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Systematic review registration<\/jats:title>\n                <jats:p>PROSPERO CRD42019137282.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13643-023-02222-4","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T03:25:54Z","timestamp":1689305154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of iron supplementation on patient outcomes for women with abnormal uterine bleeding: a protocol for a systematic review and meta-analysis"],"prefix":"10.1186","volume":"12","author":[{"given":"Hasmik","family":"Nazaryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Ellingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarni","family":"Thakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menaka","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Rochwerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Gabarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Sirotich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6489-6980","authenticated-orcid":false,"given":"Michelle P.","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"2222_CR1","unstructured":"Davis E, Sparzak PB. Abnormal uterine bleeding (dysfunctional uterine bleeding). InStatPearls 2019. Treasure Island: StatPearls Publishing."},{"key":"2222_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fertnstert.2011.03.079","volume":"113","author":"MG Munro","year":"2011","unstructured":"Munro MG, Critchley HO, Fraser IS, for the FIGO Working Group on Menstrual Disorders. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Int J Gynaecol Obstet. 2011;113:1\u20132. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.03.079.","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"2222_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1055\/s-0031-1287662","volume":"29","author":"IS Fraser","year":"2011","unstructured":"Fraser IS, Critchley HO, Broder M, Munro MG. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med. 2011;29(5):383\u201390. https:\/\/doi.org\/10.1055\/s-0031-1287662.","journal-title":"Semin Reprod Med."},{"issue":"2","key":"2222_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1586\/17474108.4.2.179","volume":"4","author":"IS Fraser","year":"2009","unstructured":"Fraser IS, Langham S, Uhl-Hochgraeber K. Health-related quality of life and economic burden of abnormal uterine bleeding. Expert Rev Obstet Gynecol. 2009;4(2):179\u201389. https:\/\/doi.org\/10.1586\/17474108.4.2.179.","journal-title":"Expert Rev Obstet Gynecol."},{"issue":"502","key":"2222_CR5","first-page":"359","volume":"54","author":"M Shapley","year":"2004","unstructured":"Shapley M, Jordan K, Croft PR. An epidemiological survey of symptoms of menstrual loss in the community. Br J Gen Pract. 2004;54(502):359\u201363.","journal-title":"Br J Gen Pract."},{"key":"2222_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3109\/00016346609158455","volume":"45","author":"L Hallberg","year":"1966","unstructured":"Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss \u2013 a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand. 1966;45:320\u201351.","journal-title":"Acta Obstet Gynecol Scand."},{"issue":"3","key":"2222_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/ijgo.12666","volume":"143","author":"MG Munro","year":"2018","unstructured":"Munro MG, Critchley HO, Fraser IS, FIGO Menstrual Disorders Committee, Haththotuwa R, Kriplani A, Bahamondes L, F\u00fcchtner C, Tonye R, Archer D, Abbott J. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynecol Obstet. 2018;143(3):393\u2013408.","journal-title":"Int J Gynecol Obstet."},{"issue":"3","key":"2222_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijgo.2014.09.027","volume":"128","author":"IS Fraser","year":"2015","unstructured":"Fraser IS, Mansour D, Breymann C, Hoffman C, Mezzacasa A, Petraglia F. Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. Int J Gynaecol Obstet. 2015;128(3):196\u2013200. https:\/\/doi.org\/10.1016\/j.ijgo.2014.09.027.","journal-title":"Int J Gynaecol Obstet."},{"key":"2222_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3109\/08880018.2014.886316","volume":"31","author":"T Gursel","year":"2014","unstructured":"Gursel T, Biri A, Kaya Z, Sivaslioglu S, Albayrak M. The frequency of menorrhagia and bleeding disorders in university students. Pediatr Hematol Oncol. 2014;31:467\u201374. https:\/\/doi.org\/10.3109\/08880018.2014.886316.","journal-title":"Pediatr Hematol Oncol."},{"key":"2222_CR10","first-page":"558","volume":"20","author":"H Kazemijaliseh","year":"2017","unstructured":"Kazemijaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Khalili D, Hosseinpanah F, Azizi F. A population-based study of the prevalence of abnormal uterine bleeding and its related factors among Iranian reproductive-age women: an updated data. Arch Iran Med. 2017;20:558\u201363.","journal-title":"Arch Iran Med."},{"issue":"2","key":"2222_CR11","first-page":"365","volume":"35","author":"S Kocaoz","year":"2019","unstructured":"Kocaoz S, Cirpan R, Degirmencioglu AZ. The prevalence and impacts heavy menstrual bleeding on anemia, fatigue and quality of life in women of reproductive age. Pakistan J Med Sci. 2019;35(2):365.","journal-title":"Pakistan J Med Sci."},{"key":"2222_CR12","unstructured":"Deli CK, Fatouros IG, Koutedakis Y, Jamurtas AZ. Iron supplementation and physical performance. Rijeka: InTech; 2013."},{"key":"2222_CR13","unstructured":"De Benoist B, Cogswell M, Egli I, McLean E. Worldwide prevalence of anaemia 1993-2005; WHO Global Database of anaemia. 2018. Retrieved from:https:\/\/www.who.int\/nutrition\/publications\/micronutrients\/anaemia_iron_deficiency\/9789241596657\/en\/."},{"key":"2222_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bpobgyn.2016.09.007","volume":"40","author":"L Percy","year":"2017","unstructured":"Percy L, Mansour D, Fraser I. Iron deficiency and iron deficiency anaemia in women. Best Pract Res Clin Obstet Gynaecol. 2017;40:55\u201367. https:\/\/doi.org\/10.1016\/j.bpobgyn.2016.09.007.","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"issue":"3","key":"2222_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/1756283X11398736","volume":"4","author":"TD Johnson-Wimbley","year":"2011","unstructured":"Johnson-Wimbley TD, Graham DY. Diagnosis and management of iron deficiency anemia in the 21st century. Therap Adv Gastroenterol. 2011;4(3):177\u201384. https:\/\/doi.org\/10.1177\/1756283X11398736.","journal-title":"Therap Adv Gastroenterol."},{"issue":"9","key":"2222_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.5694\/j.1326-5377.2010.tb04038.x","volume":"193","author":"SR Pasricha","year":"2010","unstructured":"Pasricha SR, Flecknoe-Brown SC, Allen KJ, Gibson PR, McMahon LP, Olynyk JK, et al. Diagnosis and management of iron deficiency anaemia: a clinical update. Med J Aust. 2010;193(9):525\u201332. https:\/\/doi.org\/10.5694\/j.1326-5377.2010.tb04038.x.","journal-title":"Med J Aust."},{"key":"2222_CR17","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1136\/gut.2010.228874","volume":"60","author":"AF Goddard","year":"2011","unstructured":"Goddard AF, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. Gut. 2011;60:1309\u201316. https:\/\/doi.org\/10.1136\/gut.2010.228874.","journal-title":"Gut."},{"issue":"2","key":"2222_CR18","doi-asserted-by":"publisher","first-page":"e0149881","DOI":"10.1371\/journal.pone.0149881","volume":"11","author":"G Bruinvels","year":"2016","unstructured":"Bruinvels G, Burden R, Brown N, Richards T, Pedlar C. The prevalence and impact of heavy menstrual bleeding (menorrhagia) in elite and non-elite athletes. PLoS One. 2016;11(2):e0149881. https:\/\/doi.org\/10.1371\/journal.pone.0149881.","journal-title":"PLoS One."},{"issue":"7","key":"2222_CR19","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/aogs.12394","volume":"93","author":"P Peuranp\u00e4\u00e4","year":"2014","unstructured":"Peuranp\u00e4\u00e4 P, Heli\u00f6vaara-Peippo S, Fraser I, Paavonen J, Hurskainen R. Effects of anemia and iron deficiency on quality of life in women with heavy menstrual bleeding. Acta Obstet Gynecol Scand. 2014;93(7):654\u201360. https:\/\/doi.org\/10.1111\/aogs.12394.","journal-title":"Acta Obstet Gynecol Scand."},{"issue":"4","key":"2222_CR20","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.hoc.2014.04.007","volume":"28","author":"JM Powers","year":"2014","unstructured":"Powers JM, Buchanan GR. Diagnosis and management of iron deficiency anemia. Hematol Oncol Clin North Am. 2014;28(4):729\u201345. https:\/\/doi.org\/10.1016\/j.hoc.2014.04.007.","journal-title":"Hematol Oncol Clin North Am."},{"issue":"11","key":"2222_CR21","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/ajh.23534","volume":"88","author":"M Auerbach","year":"2013","unstructured":"Auerbach M, Strauss W, Auerbach S, Rineer S, Bahrain H. Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min. Am J Hematol. 2013;88(11):944\u20137. https:\/\/doi.org\/10.1002\/ajh.23534.","journal-title":"Am J Hematol."},{"issue":"1","key":"2222_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mayocp.2014.10.007","volume":"90","author":"T Avni","year":"2015","unstructured":"Avni T, Bieber A, Mha AG, Green H, Leibovici L, Gafter-gvili A. The safety of intravenous iron preparations. Mayo Clin Proc. 2015;90(1):12\u201323. https:\/\/doi.org\/10.1016\/j.mayocp.2014.10.007.","journal-title":"Mayo Clin Proc."},{"issue":"8","key":"2222_CR23","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1111\/trf.14626","volume":"58","author":"F Khadadah","year":"2018","unstructured":"Khadadah F, Callum J, Shelton D, Lin Y. Improving quality of care for patients with iron deficiency anemia presenting to the emergency department. Transfusion. 2018;58(8):1902\u20138. https:\/\/doi.org\/10.1111\/trf.14626.","journal-title":"Transfusion."},{"issue":"9","key":"2222_CR24","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1111\/trf.12802","volume":"54","author":"JL Callum","year":"2014","unstructured":"Callum JL, Waters JH, Shaz BH, Sloan SR, Murphy MF. The AABB recommendations for the Choosing Wisely campaign of the American Board of Internal Medicine. Transfusion. 2014;54(9):2344\u201352. https:\/\/doi.org\/10.1111\/trf.12802.","journal-title":"Transfusion."},{"issue":"1","key":"2222_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.7326\/0003-4819-157-1-201206190-00429","volume":"157","author":"JL Carson","year":"2012","unstructured":"Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2012;157(1):49\u201358. https:\/\/doi.org\/10.7326\/0003-4819-157-1-201206190-00429.","journal-title":"Ann Intern Med."},{"issue":"3","key":"2222_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1017\/cem.2016.388","volume":"19","author":"J Spradbrow","year":"2017","unstructured":"Spradbrow J, Lin Y, Shelton D, Callum J. Iron deficiency anemia in the emergency department: over-utilization of red blood cell transfusion and infrequent use of iron supplementation. CJEM. 2017;19(3):167\u201374. https:\/\/doi.org\/10.1017\/cem.2016.388.","journal-title":"CJEM."},{"issue":"2","key":"2222_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jpag.2016.10.010","volume":"30","author":"AG Cooke","year":"2017","unstructured":"Cooke AG, McCavit TL, Buchanan GR, Powers JM. Iron deficiency anemia in adolescents who present with heavy menstrual bleeding. J Pediatr Adolesc Gynecol. 2017;30(2):247\u201350. https:\/\/doi.org\/10.1016\/j.jpag.2016.10.010.","journal-title":"J Pediatr Adolesc Gynecol."},{"key":"2222_CR28","doi-asserted-by":"publisher","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P). Syst Rev. 2015;4(1). https:\/\/doi.org\/10.1186\/2046-4053-4-1.","DOI":"10.1186\/2046-4053-4-1"},{"issue":"7","key":"2222_CR29","doi-asserted-by":"publisher","first-page":"1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009;6(7):1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","journal-title":"PLoS Med."},{"key":"2222_CR30","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. Revised Cochrane risk-of-bias tool for randomized trials (RoB 2). BMJ. 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ."},{"key":"2222_CR31","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [cited 2022] Retrieved from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"2222_CR32","unstructured":"GRADEpro. https:\/\/gradepro.org\/. Accessed 14 Nov 2021."}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-023-02222-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-023-02222-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-023-02222-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T03:26:38Z","timestamp":1689305198000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-023-02222-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2222"],"URL":"https:\/\/doi.org\/10.1186\/s13643-023-02222-4","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,14]]},"assertion":[{"value":"11 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MZ receives research funding from CIHR, Canadian Blood Services and Pfizer; honoraria from Pfizer, Pharmacosmos and American Society of Hematology; and has participated on Pfizer Advisory Boards. Other authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}